1. Home
  2. BOLT vs BREA Comparison

BOLT vs BREA Comparison

Compare BOLT & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • BREA
  • Stock Information
  • Founded
  • BOLT 2015
  • BREA 2022
  • Country
  • BOLT United States
  • BREA Ireland
  • Employees
  • BOLT N/A
  • BREA N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • BOLT Health Care
  • BREA Consumer Discretionary
  • Exchange
  • BOLT Nasdaq
  • BREA Nasdaq
  • Market Cap
  • BOLT 16.8M
  • BREA 13.6M
  • IPO Year
  • BOLT 2021
  • BREA 2023
  • Fundamental
  • Price
  • BOLT $5.63
  • BREA $6.62
  • Analyst Decision
  • BOLT Buy
  • BREA
  • Analyst Count
  • BOLT 3
  • BREA 0
  • Target Price
  • BOLT $50.00
  • BREA N/A
  • AVG Volume (30 Days)
  • BOLT 19.4K
  • BREA 21.9K
  • Earning Date
  • BOLT 08-12-2025
  • BREA 01-01-0001
  • Dividend Yield
  • BOLT N/A
  • BREA N/A
  • EPS Growth
  • BOLT N/A
  • BREA N/A
  • EPS
  • BOLT N/A
  • BREA N/A
  • Revenue
  • BOLT $3,638,000.00
  • BREA $2,988,009.00
  • Revenue This Year
  • BOLT N/A
  • BREA N/A
  • Revenue Next Year
  • BOLT $24.14
  • BREA N/A
  • P/E Ratio
  • BOLT N/A
  • BREA N/A
  • Revenue Growth
  • BOLT N/A
  • BREA 151.51
  • 52 Week Low
  • BOLT $5.20
  • BREA $5.00
  • 52 Week High
  • BOLT $15.60
  • BREA $19.50
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 43.75
  • BREA 49.15
  • Support Level
  • BOLT $5.62
  • BREA $6.46
  • Resistance Level
  • BOLT $6.40
  • BREA $7.61
  • Average True Range (ATR)
  • BOLT 0.29
  • BREA 0.58
  • MACD
  • BOLT 0.01
  • BREA -0.06
  • Stochastic Oscillator
  • BOLT 25.00
  • BREA 35.25

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: